Modified FOLFOX6 as a first-line treatment for patients with advanced gastric cancer with massive ascites or inadequate oral intake

BACKGROUND: Oral fluoropyrimidine plus platinum is a standard first-line treatment for advanced gastric cancer (AGC). However, this treatment is problematic for AGC patients with massive ascites or inadequate oral intake. This study aimed at evaluating the efficacy and safety of modified oxaliplatin...

全面介紹

Na minha lista:
書目詳細資料
發表在:Onco Targets Ther
Main Authors: Osumi, Hiroki, Takahari, Daisuke, Chin, Keisho, Ogura, Mariko, Ichimura, Takashi, Wakatsuki, Takeru, Suzuki, Takeshi, Ota, Yumiko, Nakayama, Izuma, Ooki, Akira, Suenaga, Mitsukuni, Shinozaki, Eiji, Yamaguchi, Kensei
格式: Artigo
語言:Inglês
出版: Dove Medical Press 2018
主題:
Original Research
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6260191/
https://ncbi.nlm.nih.gov/pubmed/30538499
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S184665
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍